NCT05116111: A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China |
|
|
| Not yet recruiting | 2 | 135 | NA | SYHA1402 tablets, Placebo | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Distal Symmetric Polyneuropathy (DSPN) | 05/23 | 06/23 | | |
